David Einhorn’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$121M Hold
4,400,641
– – 3.41% 7
2026
Q2
$130M Sell
4,400,641
-117,740
-3% -$3.02M 3.32% 5
2026
Q1
$106M Buy
4,518,381
+397,178
+10% +$7.19M 3.31% 7
2025
Q4
$58.5M Buy
4,121,203
+2,478,493
+151% +$46.9M 2.05% 15
2025
Q3
$40.7M Buy
1,642,710
+777,699
+90% +$17.4M 1.6% 19
2025
Q2
$19.6M Buy
865,011
+744,151
+616% +$17.6M 0.84% 21
2025
Q1
$3.66M Sell
120,860
-7,780
-6% -$296K 0.19% 26
2024
Q4
$5.1M Buy
+128,640
New +$5.8M 0.26% 25

Other funds holding ACHC

David Einhorn's ACHC Position: Q3 2026 in Review

David Einhorn held its Acadia Healthcare (ACHC) position steady in Q3 2026 at 4,400,641 shares worth $121M. The position accounts for 3.41% of the portfolio, ranked #7.

David Einhorn first reported a position in ACHC in Q4 2024 and has held it in 8 quarters since. The position peaked at $130M in Q2 2026. 291 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • David Einhorn held 4,400,641 shares of Acadia Healthcare worth $121M as of Q3 2026.
  • David Einhorn left its Acadia Healthcare share count unchanged in Q3 2026.
  • Acadia Healthcare made up 3.41% of David Einhorn's portfolio in Q3 2026, its #7 holding.
  • David Einhorn first reported a position in Acadia Healthcare in Q4 2024 and has held it in 8 quarters since.
  • David Einhorn's Acadia Healthcare position peaked at $130M in Q2 2026.
  • 291 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on DME Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.